stephanebancel
Following is the unofficial transcript of a CNBC interview with Moderna Inc (NASDAQ:MRNA) CEO Stephane Bancel and CNBC “Squawk Box” Co-Anchor Joe Kernen live during the D50X Summit today, Thursday, October 20th. Interview With Moderna CEO Stephane Bancel JOE KERNEN: Hello, thank you. Disruptor of the decade at least, Stephane. And it is a household name. And it’s 50 billion now, but maybe a sore subject – but it shouldn’t be – it was 150 billion at the top. So, congratulations. Q3 2022 hedge fund letters, conferences and more Find A Qualified Financial AdvisorEach advisor has been vetted by Sm...
ValueWalk
Following is the unofficial transcript of a CNBC interview with Moderna Inc (NASDAQ:MRNA) CEO Stephane Bancel on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Monday, January 10. Following are links to video on CNBC.com: Q4 2021 hedge fund letters, conferences and more Moderna CEO Bancel: Future Covid Vaccine Booster Will Likely Target Omicron VariantModerna CEO: We Can Supply Up To 3 Billion Covid Vaccine Booster Doses This YearBECKY QUICK: The annual J.P. Morgan HealthCare Conference begins today. It’s the industry’s largest healthcare investments symposium and it will be virtual once again t...
ValueWalk
CNBC Transcript: Moderna CEO Stephane Bancel speaks with CNBC’s “Squawk Box” today about developing booster shots for South African Covid strain. Q4 2020 hedge fund letters, conferences and more Moderna CEO On Developing Booster Shots For South African Covid StrainMEG TIRRELL: Well Moderna has looked at its vaccine’s effectiveness against these new variants we've been hearing about B117 and B1351, associated with the UK and South Africa, and found that against the B117 UK variant, no discernible difference in the immune response against that variant. Against the South African one, as we have b...
ValueWalk
*First on CNBC: CNBC Transcript: [Moderna](https://www.valuewalk.com/2020/11/moderna-covid-vaccine-not-94-4-effective/) CEO Stephane Bancel Speaks with CNBC’s “Squawk Box” today, about protection against severe Covid\-19 at 100% efficacy\.*Q3 2020 hedge fund letters, conferences and moreModerna CEO: Most Exciting Vaccine Data Is Protection From Severe Covid-19MEG TIRRELL: Joining us to discuss all of this is Stephane Bancel, CEO of Moderna. Stephane thanks for being with us this morning for another Monday morning of vaccine news, you know your, your answers this morning gave us a lot of the bi...
ValueWalk
First on CNBC: CNBC Transcript: Moderna CEO Stephane Bancel speaks with CNBC’s “Squawk Box” today on their 94.5% effective Covid vaccineQ3 2020 hedge fund letters, conferences and moreModerna CEO Stephane Bancel on its 94.5% effective Covid vaccine: We hope to get it to market soonAll references must be sourced to CNBC.BECKY QUICK: All right, listen up everybody some breaking news from Moderna. Meg Tirell joins us right now with the headlines and special guest, Meg, take it away.MEG TIRRELL: Hi Becky well we're getting Moderna is phase three interim results 94.5% advocacy for their COVID-19 va...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら